News
Stay Ahead with the Latest Industry Trends & Market Insights with Industry News đź“°

North America Organ Preservation Market Size, Share, Industry, Forecast and Outlook (2024-2031)

North America Organ Preservation Market is segmented By Transportation Technique (Static Cold Storage (SCS), Hypothermic Perfusion Preservation (HPP), Normothermic Machine Perfusion, and Others) By Preservation Solution (University of Wisconsin Solution, Custodiol HTK, Perfadex, and Others) By Organ Type (Kidney, Liver, Lung, and Others), and By Region (US, Canada, and Rest of North America)

Published: May 2025 || SKU: HCIT6929
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
Get Free Sample

Get Expert Insights on North America Organ Preservation Market

Talk to

North America Organ Preservation Market Overview

The North America Organ Preservation Market is expected to grow at a CAGR of 9% during the forecast period 2024-2031.

Organ transplantation entails removing an organ from a donor body, transferring the organ, and transplanting the organ into another body while protecting the organ from major harm. Although inducing hypothermia by lowering organ temperature may aid in preservation, distinct bodily organs need specific and suitable storage settings to sustain their anatomical and physiological activities.

 The growing prevalence of organ failure, increased research and development, technological improvements, and rising chronic renal disease are the primary driving factors projected to fuel market growth.

Market Summary and Scope

MetricsDetails
CAGR9%
Size Available for Years2021-2030
Forecast Period2023-2030
Data AvailabilityValue (US$)
Segments CoveredTransportation Technique, Preservation Solution, and Organ Type
Countries CoveredUS, Canada, and Rest of North America
Report Insights CoveredCompetitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.

 

For more details on this report Request for Sample

 

Market Growth Factors

The North American organ preservation demand is on the rise due to rising number of cases of organ failure. In addition, the increasing incidence of organ failure and the growing amount of organ transplant surgeries in North America are driving the market forward.

One of the key factors in Cardiovascular Diseases has become one of the most prevalent causes of death and morbidity during the preceding three decades. Coronary artery disease, arrhythmias, peripheral vascular disease, heart failure, and congenital heart abnormalities are the most prevalent cardiovascular illnesses in North America.

The increased incidence of renal failure and chronic kidney disease is expected to fuel market growth. Furthermore, the rising frequency of chronic liver disease and cirrhosis in North America is likely to drive market growth.

The major growth factors for the organ preservation market are increasing incidences of organ failures occurring globally due to the rapid growth of the senior population, as well as various regional authorities providing favorable regulations, organizing initiatives, and developing awareness programs to increase the volume of organ donations and transplantation procedures in North America.

Market Segmentation Analysis

The North America Organ Preservation Market is segmented by transportation technique, preservation solution, and organ type.

Transportation Technique: The Static Cold Storage Segment is Expected to Grow at the Fastest CAGR During the Forecast Period

The static cold storage (SCS) segment has the largest market share in the North America organ preservation market due to a rise in the number of organ failures, which has led to a growth in organ transplantation and research activities. Static cold storage involves the movement of donated organs on ice. For many decades, it has been the finest standard for the preservation of various organizations.

Static cold storage is based on hypothermia, which reduces the demand for oxygen as well as cellular metabolism, allowing for the preservation of organs to last longer. Cold storage reduces metabolic activity by around tenfold and promotes anaerobic metabolism, which interrupts the energy cycle. According to the nature journal article "Organ Preservation: From Past to Future," static cold storage is the most successful and easy method for organ preservation and transportation. This is the most prevalent strategy for organ preservation.

Market Regional Insights

Based on region, the North America organ preservation market is segmented into US, Canada, and Rest of North America.

Geographically, North America led the Organ Preservation Market with a 39 per cent market share. The increasing use of enhanced medical technology and increased development by organ preservation businesses are prominent factors driving the market throughout the projected period.

North America led the market in 2022 and is projected to do this shortly. The increased acceptance of novel healthcare technologies, the high incidence of chronic renal illness and heart failure, enhanced reimbursement laws, and increased expenditures in healthcare infrastructure are all propelling the industry forward.

Market Competitive Landscape

The key players operating in the North America organ preservation market are Essential Pharmaceuticals, Dr. Franz Kohler Chemie GmbH, Organ Recovery Systems, Xvivo Perfusion AB, and Waters Medical Systems LLC.

Why purchase North America Organ Preservation Market report?

Technological Innovations

Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.

Product Performance & Market Positioning

Analyzes product performance, market positioning, and growth potential to optimize strategies.

Real-World Evidence

Integrates patient feedback and data into product development for improved outcomes.

Physician Preferences & Health System Impact

Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.

Market Updates & Industry Changes

Covers recent regulatory changes, new policies, and emerging technologies.

Competitive Strategies

Analyzes competitor strategies, market share, and emerging players.

Pricing & Market Access

Reviews pricing models, reimbursement trends, and market access strategies.

Market Entry & Expansion

Identifies optimal strategies for entering new markets and partnerships.

Regional Growth & Investment

Highlights high-growth regions and investment opportunities.

Supply Chain Optimization

Assesses supply chain risks and distribution strategies for efficient product delivery.

Sustainability & Regulatory Impact

Focuses on eco-friendly practices and evolving regulations in healthcare.

Post-market Surveillance

Uses post-market data to enhance product safety and access.

Pharmacoeconomics & Value-Based Pricing

Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2025

Manufacturers

Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.

Regulatory & Policy

Compliance Officers, Government, Health Economists, Market Access Specialists.

Application & Innovation

AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.

Investors

Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.

Consulting & Advisory

Healthcare Consultants, Industry Associations, Analysts.

Supply Chain

Distribution and Supply Chain Managers.

Consumers & Advocacy

Patients, Advocacy Groups, Insurance Companies.

Academic & Research

Academic Institutions.

Buy this report
Single User
$3750
Multiple User
$4000
Enterprise User
$7250
Proceed to Buy
  Get Free Sample
  Customize Sample
  Demo Full Report
Chat on WhatsApp
WhatsApp